N2OFF

Price & Volume

Stats

52W Range	$1.45-$59.50
Market Cap	$4.2M
Shares Short	8,921

Financials

Revenue (12 Mos)	$209,000
Revenue Growth (YoY)	-77.8%
Gross Profit (12 Mos)	$135,000
Diluted EPS	-$12.75

News

Yahoo Finance • 2 months ago

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

Yahoo Finance • 2 months ago

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers

Yahoo Finance • 3 months ago

SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition

Yahoo Finance • 3 months ago

SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

About

CFO	Ms. Lital Barda
Address	HaPardes 134, Meshek Sander, Hod HaSharon, Israel, 4994500
Sector	Basic Materials
Industry	Agricultural Inputs
Full-Time Employees	3